Diabetes Mellitus - Type 2 | Obesity & Weight Control, Phase III
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once-Weekly Eloralintide versus Placebo in Adult Participants with Obesity who are on stable incretin background.
Volunteers
Health Professionals
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated07/12/2026
- Study IRB#2000041604